Dalal Sulaiman Alshaya

October 13, 2025

Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential

Abstract Background: EME1, a critical DNA repair endonuclease, has emerged as a potential oncogene implicated in genome instability and cancer…

May 30, 2024

ACTL6A: unraveling its prognostic impact and paving the way for targeted therapeutics in carcinogenesis

Abstract Introduction: Increased Actin-like 6A (ACTL6A) expression is associated with various cancers, but its comprehensive investigation across different malignancies is…

August 11, 2023

Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome

Abstract Cyclin dependent kinase inhibitor 2A (CDKN2A) is a well-known tumor suppressor gene as it functions as a cell cycle…